DNLI Kronos AI forecast
A 30-trading-day price forecast for Denali Therapeutics Inc. (DNLI) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Denali Therapeutics Inc. at $20.55 on 2026-12-08, +6.9% from the last close of $19.22 on 2026-10-27. Eight out of ten sampled paths end between $19.35 and $21.12, and 7 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of DNLI
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $19.13 | $18.60 | $20.24 |
| 2026-11-10 | $19.60 | $18.91 | $21.34 |
| 2026-11-17 | $19.66 | $19.19 | $21.53 |
| 2026-11-24 | $20.35 | $18.97 | $21.35 |
| 2026-12-01 | $20.39 | $19.34 | $21.00 |
| 2026-12-08 | $20.55 | $19.35 | $21.12 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for DNLI?
- Kronos AI's median forecast for DNLI is $20.55 in 30 trading days, +6.9% from the last close, with a 10–90% range of $19.35 to $21.12.
- Is the DNLI Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.